Lataa...

Biomarkers and surrogate endpoints in kidney disease

Kidney disease and its related comorbidities impose a large public health burden. Despite this, the number of clinical trials in nephrology lags behind many other fields. An important factor contributing to the relatively slow pace of nephrology trials is that existing clinical endpoints have signif...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Nephrol
Päätekijä: Hartung, Erum A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4646734/
https://ncbi.nlm.nih.gov/pubmed/25980469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-015-3104-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!